Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 17 to 21, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Booster shots are keeping the Omicron variant from landing millions of Americans in hospitals, emergency rooms and urgent care clinics across the country, three new government studies show.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Some kids might be able to get over their peanut allergy if they start immunotherapy while they're still toddlers, a major new clinical trial reports.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Vaccine effectiveness against symptomatic COVID-19 decreases by 20 weeks after the second dose of BNT162b2 or CHAdOx1-S, but limited waning is seen against COVID-19-related hospitalization and death, according to a study published online Jan. 12 in the New England Journal of Medicine.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Biosimilar drugs could drive down prices for biologic drugs and generate savings of about $38.4 billion between 2021 and 2025, according to a study published online Jan. 3 in the American Journal of Managed Care.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- The risk of hospitalization for COVID-19 among older Americans is far higher for those who are unvaccinated than for those who are fully vaccinated and have had a booster shot, new government data shows.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.
THURSDAY, Jan. 20, 2022 (HealthDay News) -- There is no evidence to support administering antibiotic prophylaxis before invasive dental procedures (IDP) in patients with prosthetic joints, according to a study published online Jan. 19 in JAMA Network Open.
THURSDAY, Jan. 20, 2022 (HealthDay News) -- Having a child with type 1 diabetes can be a challenging health condition for parents to manage, but new research suggests an "artificial pancreas" system may beat standard treatment in controlling the blood sugar disease in young children.
THURSDAY, Jan. 20, 2022 (HealthDay News) -- Most emergency department interventions aimed at cutting opioid prescribing cut the prescription rate but not the prescribed opioid quantity, according to a review published online Jan. 13 in JAMA Network Open.
